The Severe Combined Immunodeficiency (SCID) Gene Panel uses advanced Next-Generation Sequencing (NGS) to identify mutations that cause profound immune dysfunction. Metropolis Healthcare analyzes an EDTA blood sample to detect defects affecting T-cell, B-cell, or NK-cell development. This test supports early and accurate diagnosis, which is essential for timely treatment. It also provides valuable insights for long-term management and genetic counseling
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the SCID Gene Panel include?
This panel at Metropolis Healthcare includes comprehensive NGS analysis of genes linked to Severe Combined Immunodeficiency and other related immunological disorders.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-depth sequencing platforms to detect pathogenic mutations, including point variants, deletions, insertions, and other clinically relevant changes.
Who should take this test?
Newborns, infants, or individuals with recurrent severe infections, poor immune response, or suspected SCID should consider this test at Metropolis Healthcare.
Why is this test important?
It enables early diagnosis of SCID, allowing timely interventions such as stem cell transplantation, supported by Metropolis Healthcare’s advanced genetic diagnostics.
What sample is required for the test?
An EDTA blood sample is needed, from which Metropolis Healthcare extracts DNA for sequencing and analysis.
Can this test help in treatment planning?
Yes, the detailed results from Metropolis Healthcare guide clinicians in selecting appropriate therapies and monitoring immune recovery.
Is this test suitable for newborn screening?
Yes, Metropolis Healthcare performs this test for newborns and infants where early detection is vital for survival.
Does this test support genetic counseling?
Absolutely. Metropolis Healthcare provides detailed interpretation that helps families understand inheritance risks and future reproductive planning.